Pyelonephritis

Basics

Description

  • A syndrome caused by infection of the renal parenchyma and/or renal pelvis, often producing localized flank/back pain combined with systemic symptoms, such as fever, chills, nausea and vomiting; there is a wide spectrum of illness ranging from mild symptoms to septic shock.
  • Chronic pyelonephritis is the result of progressive inflammation of the renal interstitium and tubules, due to recurrent infection, vesicoureteral reflux, or both.
  • Pyelonephritis is considered uncomplicated if the infection is caused by a typical pathogen in an immunocompetent patient with normal urinary tract anatomy and renal function.
  • System(s) affected: renal; urologic
  • Synonym: acute upper urinary tract infection (UTI)

Geriatric Considerations

  • May present as altered mental status; absence of fever is common in the elderly.
  • Older patients with diabetes and pyelonephritis are at higher risk for bacteremia, prolonged hospitalization, and mortality.
  • The high prevalence of asymptomatic bacteriuria in the elderly makes the use of urine dipstick less reliable for diagnosing UTI in this population.

Pregnancy Considerations

  • Most common medical complication requiring hospitalization. Pregnant women with asymptomatic bacteriuria (ABU) have 20–30% risk to develop acute pyelonephritis if ABU is not treated.
  • Affects 1–2% of all pregnancies. Morbidity does not differ between trimesters.
  • Urine culture for test of cure 1 to 2 weeks after therapy.
  • Consider low-dose suppressive antibiotics for the remainder of pregnancy following treatment for pyelonephritis or recurrent cystitis in pregnancy.

Pediatric Considerations

  • UTI is present in ~5% of patients age 2 months to 2 years with fever and no apparent source on history and physical exam.
  • Treatment (PO or IV; inpatient or outpatient) should be based on the clinical situation and patient toxicity.

Epidemiology

Incidence
Community-acquired acute pyelonephritis: 3 to 4 cases per 10,000 males; 15 to 17 cases per 10,000 females; 28 cases per 10,000 women ages 18 to 49 years.

Prevalence
Adult cases: 250,000/year, with 200,000 hospitalizations

Etiology and Pathophysiology

  • Escherichia coli (>80%)
  • Other gram-negative pathogens: Proteus, Klebsiella, Serratia, Clostridium, Pseudomonas, and Enterobacter spp.
  • Enterococcus spp.
  • Staphylococcus: Staphylococcus epidermidis, Staphylococcus saprophyticus (number 2 cause in young women), and Staphylococcus aureus
  • Candida spp.

Risk Factors

  • Underlying urinary tract abnormalities
  • Indwelling catheter/recent urinary tract instrumentation
  • Nephrolithiasis
  • Immunocompromised, including diabetes
  • Elderly, institutionalized patients (particularly women)
  • Prostatic enlargement, stress incontinence
  • Childhood UTI
  • Acute pyelonephritis within the prior year
  • Recent sexual intercourse; spermicide use; new sex partner within the prior year
  • Pregnancy
  • Hospital-acquired infection
  • Symptoms >7 days at time of presentation

Commonly Associated Conditions

  • Indwelling catheters, renal calculi
  • Benign prostatic hyperplasia

There's more to see -- the rest of this topic is available only to subscribers.